Lichtenstein Patch or Prolene Hernia System (PHS) for Inguinal Hernia Repair
Randomized Clinical Trial of Lichtenstein Patch or Prolene Hernia System for Inguinal Hernia Repair
1 other identifier
interventional
300
1 country
1
Brief Summary
This randomised prospective study was designed to compare the convalescence and the long-term sequelae in inguinal hernia repair with either a bilayer mesh as devised by Gilbert (Prolene Hernia System®) or an onlay mesh applied according to Lichtenstein.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable chronic-pain
Started Sep 2001
Longer than P75 for not_applicable chronic-pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2001
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2005
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2009
CompletedFirst Submitted
Initial submission to the registry
February 17, 2010
CompletedFirst Posted
Study publicly available on registry
February 18, 2010
CompletedResults Posted
Study results publicly available
January 16, 2014
CompletedJanuary 16, 2014
December 1, 2013
3.3 years
February 17, 2010
December 2, 2013
December 2, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Long-term Sequelae
Any pain at five years
5 years
Study Arms (2)
Prolene Hernia System device
EXPERIMENTALInguinal hernia repair either with a bilayer mesh (PHS)
Lichtenstein
EXPERIMENTALInguinal hernia repair with the Lichtenstein technique
Interventions
Inguinal hernia repair either with the bilayer mesh or the Lichtenstein technique
Eligibility Criteria
You may qualify if:
- Uni- or bilateral
- Primary or recurrent
You may not qualify if:
- body-mass index over 40kg/m2, severe co-morbidities
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Helsinki University Central Hospital
Espoo, 07430, Finland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Georgios Pierides
- Organization
- Helsinki University Central Hospital
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Consultant
Study Record Dates
First Submitted
February 17, 2010
First Posted
February 18, 2010
Study Start
September 1, 2001
Primary Completion
January 1, 2005
Study Completion
December 1, 2009
Last Updated
January 16, 2014
Results First Posted
January 16, 2014
Record last verified: 2013-12